| - SMTL ID
- 4b9k.1
- Ligands
- (2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b9k.2
- Ligands
- ACETATE ION; (2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b9k.3
- Ligands
- ACETATE ION; (2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 4b9k.4
- Ligands
- ACETATE ION; (2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|